4.3 Article

Discordance between self-reported contraceptive use and detection of exogenous hormones among Malawian women enrolling in a randomized clinical trial

Journal

CONTRACEPTION
Volume 97, Issue 4, Pages 354-356

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.contraception.2017.12.007

Keywords

Contraceptive use; Medroxyprogesterone acetate (MPA); Levonorgestrel (LNG); Misreporting; Discordance

Funding

  1. U.S. Centers for Disease Control and Prevention (CDC) [U48DP001944, 200-2015-M-63021]
  2. National Institutes of Health (NIH) [1K01-TW009657-01, P30-AI50410]
  3. Bill & Melinda Gates Foundation [OPP1090837]
  4. U.S. Agency for International Development [AID-OAA-A-15-00045]
  5. Bill and Melinda Gates Foundation [OPP1090837] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

Objective: The objective was to assess the extent of concordance between self-reported contraceptive use and the presence of contraceptive progestins in serum. Study design: We evaluated self-reported contraceptive use by using radioimmunoassay to examine baseline serum levels of medroxyprogesterone acetate (MPA) and levonorgestrel (LNG) among 97 Malawian women enrolling in a contraceptive trial. Results: Twelve percent (12/97) of study participants who reported no hormonal contraceptive use in the previous 6 months had either MPA or LNG detected in their serum. Conclusions: The observed discordance between self-report and detection of exogenous hormones in serum indicates that caution is warranted when drawing conclusions based on self-reported contraceptive use. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available